Get the Stockscreener App
1.63
0.61%
-0.01
After Hours:
1.63
Therapeuticsmd Inc stock is traded at $1.63, with a volume of 68,705.
It is down -0.61% in the last 24 hours and down -4.12% over the past month.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
See More
Previous Close:
$1.64
Open:
$1.67
24h Volume:
68,705
Relative Volume:
0.31
Market Cap:
$18.87M
Revenue:
$996.00K
Net Income/Loss:
$-6.09M
P/E Ratio:
-3.0755
EPS:
-0.53
Net Cash Flow:
$-9.76M
1W Performance:
-4.12%
1M Performance:
-4.12%
6M Performance:
+40.52%
1Y Performance:
+89.53%
1-Day Range:
$1.60
$1.69
1-Week Range:
$1.60
$1.78
52-Week Range:
$0.72
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Name
Therapeuticsmd Inc
Sector
Phone
561-961-1900
Address
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Compare TXMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.63 | 18.98M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
125.82 | 55.71B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.59 | 49.38B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.11 | 44.89B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.21 | 35.96B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
487.25 | 21.36B | 3.08B | 1.24B | 1.07B | 25.61 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-20 | Downgrade | Jefferies | Hold → Underperform |
| May-19-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-02-19 | Initiated | Guggenheim | Buy |
| Oct-17-19 | Initiated | H.C. Wainwright | Buy |
| Apr-30-19 | Resumed | Noble Capital Markets | Outperform |
| Jun-15-18 | Initiated | JP Morgan | Overweight |
| Sep-08-17 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-11-17 | Upgrade | Oppenheimer | Perform → Outperform |
| May-09-17 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-22-16 | Resumed | Jefferies | Buy |
| Nov-22-16 | Initiated | Oppenheimer | Outperform |
| Nov-07-16 | Resumed | Guggenheim | Buy |
| Apr-04-16 | Initiated | Goldman | Buy |
| Dec-08-15 | Reiterated | Jefferies | Buy |
| Dec-08-15 | Reiterated | Stifel | Buy |
| Sep-21-15 | Reiterated | Jefferies | Buy |
| Jun-09-15 | Initiated | Guggenheim | Buy |
| Jul-08-14 | Initiated | FBR Capital | Outperform |
| Apr-17-14 | Reiterated | Noble Financial | Buy |
| Jan-28-14 | Reiterated | Noble Financial | Buy |
View All
Therapeuticsmd Inc Stock (TXMD) Latest News
TherapeuticsMD Inc. Stock Slips 3.4%, Underperforms Market - 富途牛牛
TherapeuticsMD Inc. Stock Rallies 3.7%, Outperforms Market - 富途牛牛
TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
Why hedge funds are buying TherapeuticsMD Inc. stockWeekly Trade Report & Intraday High Probability Setup Alerts - Улправда
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
Is TherapeuticsMD Inc. stock a safe haven assetJuly 2025 Opening Moves & Target Return Focused Stock Picks - Bölüm Sonu Canavarı
Rate Cut: Will TherapeuticsMD Inc. stock deliver long term returnsEarnings Overview Report & AI Powered Market Entry Strategies - Улправда
How strong is TherapeuticsMD Inc. stock revenue growthGlobal Markets & AI Driven Stock Reports - DonanımHaber
MSN Money - MSN
Block Trades: How currency fluctuations impact TherapeuticsMD Inc. stock2025 Momentum Check & Advanced Technical Analysis Signals - ulpravda.ru
How supply chain issues affect TherapeuticsMD Inc. stockJuly 2025 Highlights & Long-Term Capital Growth Strategies - Улправда
Dilution adjustment of TherapeuticsMD, Inc. – FWB:29TA - TradingView — Track All Markets
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Approves Key Proposals at Annual Meeting - TipRanks
TherapeuticsMD (NASDAQ: TXMD) investors approve 2025 votes, 640M share authorization - Stock Titan
Price to earnings ratio of TherapeuticsMD, Inc. – DUS:29TA - TradingView — Track All Markets
29TA Stock Price and Chart — DUS:29TA - TradingView — Track All Markets
TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch
TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Dip Buying: Is TherapeuticsMD Inc stock attractive for income investorsIPO Watch & AI Based Trade Execution Alerts - moha.gov.vn
With TherapeuticsMD Stock Surging, Have You Considered The Downside? - Trefis
TherapeuticsMD (TXMD) Stock Analysis Report | Financials & Insights - Benzinga
TherapeuticsMD, Inc. (TXMD) -6.3% in After-hours: Price Decline Despite Recent Results - Stocks Telegraph
Will TherapeuticsMD Inc. (29TA) stock profit from automation waveEarnings Miss & Weekly Watchlist of Top Performers - Newser
Will TherapeuticsMD Inc. (29TA) stock sustain bullish trend into 2025Trade Risk Summary & Safe Entry Zone Identification - Newser
Can TherapeuticsMD Inc. (29TA) stock test all time highsJuly 2025 Setups & Step-by-Step Trade Execution Guides - Newser
Is TherapeuticsMD Inc. stock affected by interest rate hikes - Newser
TherapeuticsMD Inc. Stock Sheds 3.9%, Underperforms Market - 富途牛牛
TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors - 富途牛牛
TherapeuticsMD Announces Pricing of Offering of Common Stock - AOL.com
TherapeuticsMD, Inc. (TXMD) 5.48% in After-hours: What’s Driving the Move? - Stocks Telegraph
TherapeuticsMD Inc Stock Analysis and ForecastCandlestick Trading Patterns & Low Risk Trading Plans - earlytimes.in
TherapeuticsMD Inc. Stock Falls 7.9%, Underperforms Market - 富途牛牛
What drives TherapeuticsMD Inc 29TA stock priceSupport Zone Identification & High Return Stock Ideas - earlytimes.in
Is TherapeuticsMD Inc. stock a buy before product launchesWeekly Trade Report & Weekly Breakout Watchlists - newser.com
Is TherapeuticsMD Inc. (29TA) stock supported by strong fundamentalsAnalyst Downgrade & Expert Curated Trade Ideas - newser.com
Can TherapeuticsMD Inc. stock hit analyst price targets2025 Earnings Surprises & Verified High Yield Trade Plans - newser.com
Will TherapeuticsMD Inc. (29TA) stock outperform energy sector in 2025Portfolio Update Summary & AI Enhanced Trading Signals - newser.com
Will TherapeuticsMD Inc. (29TA) stock hit Wall Street targetsPortfolio Performance Summary & Risk Controlled Swing Alerts - newser.com
How TherapeuticsMD Inc. (29TA) stock responds to bond marketMarket Volume Summary & Consistent Return Investment Signals - newser.com
Why TherapeuticsMD Inc. stock is seen as undervaluedQuarterly Market Summary & Daily Stock Trend Watchlist - newser.com
Therapeuticsmd Inc Stock (TXMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.30%
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):